These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1813 related articles for article (PubMed ID: 34370972)

  • 1. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study.
    Perry RJ; Tamborska A; Singh B; Craven B; Marigold R; Arthur-Farraj P; Yeo JM; Zhang L; Hassan-Smith G; Jones M; Hutchcroft C; Hobson E; Warcel D; White D; Ferdinand P; Webb A; Solomon T; Scully M; Werring DJ; Roffe C;
    Lancet; 2021 Sep; 398(10306):1147-1156. PubMed ID: 34370972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
    Kim AY; Woo W; Yon DK; Lee SW; Yang JW; Kim JH; Park S; Koyanagi A; Kim MS; Lee S; Shin JI; Smith L
    Int J Infect Dis; 2022 Jun; 119():130-139. PubMed ID: 35339716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    Pavord S; Scully M; Hunt BJ; Lester W; Bagot C; Craven B; Rampotas A; Ambler G; Makris M
    N Engl J Med; 2021 Oct; 385(18):1680-1689. PubMed ID: 34379914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.
    Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C
    Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase.
    van de Munckhof A; Lindgren E; Kleinig TJ; Field TS; Cordonnier C; Krzywicka K; Poli S; Sánchez van Kammen M; Borhani-Haghighi A; Lemmens R; Scutelnic A; Ciccone A; Gattringer T; Wittstock M; Dizonno V; Devroye A; Elkady A; Günther A; Cervera A; Mengel A; Chew BLA; Buck B; Zanferrari C; Garcia-Esperon C; Jacobi C; Soriano C; Michalski D; Zamani Z; Blacquiere D; Johansson E; Cuadrado-Godia E; Vuillier F; Bode FJ; Caparros F; Maier F; Tsivgoulis G; Katzberg HD; Duan J; Burrow J; Pelz J; Mbroh J; Oen J; Schouten J; Zimmermann J; Ng K; Garambois K; Petruzzellis M; Carvalho Dias M; Ghiasian M; Romoli M; Miranda M; Wronski M; Skjelland M; Almasi-Dooghaee M; Cuisenier P; Murphy S; Timsit S; Coutts SB; Schönenberger S; Nagel S; Hiltunen S; Chatterton S; Cox T; Bartsch T; Shaygannejad V; Mirzaasgari Z; Middeldorp S; Levi MM; Kremer Hovinga JA; Jood K; Tatlisumak T; Putaala J; Heldner MR; Arnold M; Aguiar de Sousa D; Ferro JM; Coutinho JM;
    Stroke; 2022 Oct; 53(10):3206-3210. PubMed ID: 36082668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.
    Sharifian-Dorche M; Bahmanyar M; Sharifian-Dorche A; Mohammadi P; Nomovi M; Mowla A
    J Neurol Sci; 2021 Sep; 428():117607. PubMed ID: 34365148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 Vaccination.
    Scutelnic A; Krzywicka K; Mbroh J; van de Munckhof A; van Kammen MS; de Sousa DA; Lindgren E; Jood K; Günther A; Hiltunen S; Putaala J; Tiede A; Maier F; Kern R; Bartsch T; Althaus K; Ciccone A; Wiedmann M; Skjelland M; Medina A; Cuadrado-Godia E; Cox T; Aujayeb A; Raposo N; Garambois K; Payen JF; Vuillier F; Franchineau G; Timsit S; Bougon D; Dubois MC; Tawa A; Tracol C; De Maistre E; Bonneville F; Vayne C; Mengel A; Michalski D; Pelz J; Wittstock M; Bode F; Zimmermann J; Schouten J; Buture A; Murphy S; Palma V; Negro A; Gutschalk A; Nagel S; Schoenenberger S; Frisullo G; Zanferrari C; Grillo F; Giammello F; Martin MM; Cervera A; Burrow J; Esperon CG; Chew BLA; Kleinig TJ; Soriano C; Zimatore DS; Petruzzellis M; Elkady A; Miranda MS; Fernandes J; Vogel ÅH; Johansson E; Philip AP; Coutts SB; Bal S; Buck B; Legault C; Blacquiere D; Katzberg HD; Field TS; Dizonno V; Gattringer T; Jacobi C; Devroye A; Lemmens R; Kristoffersen ES; di Poggio MB; Ghiasian M; Karapanayiotides T; Chatterton S; Wronski M; Ng K; Kahnis R; Geeraerts T; Reiner P; Cordonnier C; Middeldorp S; Levi M; van Gorp ECM; van de Beek D; Brodard J; Kremer Hovinga JA; Kruip MJHA; Tatlisumak T; Ferro JM; Coutinho JM; Arnold M; Poli S; Heldner MR
    Ann Neurol; 2022 Oct; 92(4):562-573. PubMed ID: 35689346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
    Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
    JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia.
    Huynh A; Arnold DM; Ivetic N; Clare R; Hadzi-Tosev M; Liu Y; Smith JW; Bissola AL; Daka M; Kelton JG; Nazy I
    J Thromb Haemost; 2023 Oct; 21(10):2833-2843. PubMed ID: 37394121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.
    Rodriguez EVC; Bouazza FZ; Dauby N; Mullier F; d'Otreppe S; Jissendi Tchofo P; Bartiaux M; Sirjacques C; Roman A; Hermans C; Cliquennois M
    Infection; 2022 Apr; 50(2):531-536. PubMed ID: 34626338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem.
    Clarke L; Brighton T; Chunilal SD; Lee CSM; Passam F; Curnow J; Chen VM; Tran HA
    Vaccine; 2023 May; 41(20):3285-3291. PubMed ID: 37085453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19.
    Scutelnic A; van de Munckhof A; Krzywicka K; van Kammen MS; Lindgren E; Cordonnier C; Kleinig TJ; Field TS; Poli S; Lemmens R; Middeldorp S; Aaron S; Borhani-Haghighi A; Arauz A; Kremer Hovinga JA; Günther A; Putaala J; Wasay M; Conforto AB; de Sousa DA; Jood K; Tatlisumak T; Ferro JM; Coutinho JM; Arnold M; Heldner MR;
    Eur Stroke J; 2023 Dec; 8(4):1001-1010. PubMed ID: 37434312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More.
    Lippi G; Favaloro EJ
    Semin Thromb Hemost; 2022 Feb; 48(1):8-14. PubMed ID: 34695859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia.
    Krzywicka K; Aguiar de Sousa D; Cordonnier C; Bode FJ; Field TS; Michalski D; Pelz J; Skjelland M; Wiedmann M; Zimmermann J; Wittstock M; Zanotti B; Ciccone A; Bandettini di Poggio M; Borhani-Haghighi A; Chatterton S; Aujayeb A; Devroye A; Dizonno V; Geeraerts T; Giammello F; Günther A; Ichaporia NR; Kleinig T; Kristoffersen ES; Lemmens R; De Maistre E; Mirzaasgari Z; Payen JF; Putaala J; Petruzzellis M; Raposo N; Sadeghi-Hokmabadi E; Schoenenberger S; Umaiorubahan M; Sylaja PN; van de Munckhof A; Sánchez van Kammen M; Lindgren E; Jood K; Scutelnic A; Heldner MR; Poli S; Kruip MJHA; Arauz A; Conforto AB; Aaron S; Middeldorp S; Tatlisumak T; Arnold M; Coutinho JM; Ferro JM;
    Eur J Neurol; 2023 May; 30(5):1335-1345. PubMed ID: 36773014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia following COVID-19 Vaccine: A Case Report with Systematic Review of the Literature.
    Cascio Rizzo A; Giussani G; Agostoni EC
    Cerebrovasc Dis; 2022; 51(6):722-734. PubMed ID: 35512656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.
    Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP
    Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
    Greinacher A; Selleng K; Mayerle J; Palankar R; Wesche J; Reiche S; Aebischer A; Warkentin TE; Muenchhoff M; Hellmuth JC; Keppler OT; Duerschmied D; Lother A; Rieg S; Gawaz MP; Mueller KAL; Scheer CS; Napp M; Hahnenkamp K; Lucchese G; Vogelgesang A; Flöel A; Lovreglio P; Stufano A; Marschalek R; Thiele T;
    Blood; 2021 Oct; 138(14):1269-1277. PubMed ID: 34280256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
    Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D
    Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report.
    Di Pietro M; Dono F; Consoli S; Evangelista G; Pozzilli V; Calisi D; Barbone F; Bonanni L; Onofrj M; De Angelis MV; Sensi SL
    Neurol Sci; 2022 May; 43(5):2951-2956. PubMed ID: 35217969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.
    Favaloro EJ
    Int J Lab Hematol; 2021 Aug; 43(4):559-570. PubMed ID: 34138513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 91.